The MAPK1/3 pathway is essential for the deregulation of autophagy observed in G2019S LRRK2 mutant fibroblasts

被引：20
|
作者：
Bravo-San Pedro, Jose M. [1 ]
Gomez-Sanchez, Ruben [1 ]
Niso-Santano, Mireia [1 ]
Pizarro-Estrella, Elisa [1 ]
Aiastui-Pujana, Ana [2 ]
Gorostidi, Ana [2 ]
Climent, Vicente [3 ]
Lopez de Maturana, Rakel [4 ]
Sanchez-Pernaute, Rosario [4 ]
Lopez de Munain, Adolfo [5 ]
Fuentes, Jose M. [1 ]
Gonzalez-Polo, Rosa A. [1 ]
机构：
[1] Univ Extremadura, Dept Bioquim & Biol Mol & Genet, E Enfermeria & TO, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Caceres, Spain
[2] Ilundain Fdn, Hosp Donosti, Lab Neurogenet, San Sebastian, Spain
[3] Univ Extremadura, Fac Med, Dept Anat & Embriol Humana, Badajoz, Spain
[4] Fdn Inbiomed, Lab Celulas Madre & Neurorreparac, San Sebastian, Spain
[5] Hosp Donosti, Serv Neurol, Inst Biodonostia, Ctr Invest Biomed Red Enfermedades Neurodegenerat, San Sebastian, Spain
来源：
AUTOPHAGY | 2012年 / 8卷 / 10期
关键词：
autophagy; LRRK2; G2019S; MAPK1/3; Parkinson disease;
D O I：
10.4161/auto.21270
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
The link between the deregulation of autophagy and cell death processes can be essential in the development of several neurodegenerative diseases, such as Parkinson disease (PD). However, the molecular mechanism of deregulation of this degradative process in PD patients is unknown. The leucine-rich repeat kinase 2 (LRRK2) gene is related to PD and its implication in autophagy regulation has been described. Our recent work shows that the presence of the G2019S LRRK2 mutation, one of the most prevalent in LRRK2, is accompanied by a deregulation of autophagy basal levels dependent on the MAPK1/3 (ERK2/1) pathway. © 2012 Landes Bioscience.
引用
收藏
页码：1537 / 1539
页数：3
相关论文
共 24 条
  • [1] The LRRK2 G2019S mutant exacerbates basal autophagy through activation of the MEK/ERK pathway
    Bravo-San Pedro, Jose M.
    Niso-Santano, Mireia
    Gomez-Sanchez, Ruben
    Pizarro-Estrella, Elisa
    Aiastui-Pujana, Ana
    Gorostidi, Ana
    Climent, Vicente
    Lopez de Maturana, Rakel
    Sanchez-Pernaute, Rosario
    Lopez de Munain, Adolfo
    Fuentes, Jose M.
    Gonzalez-Polo, Rosa A.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2013, 70 (01) : 121 - 136
  • [2] The LRRK2 G2019S mutant exacerbates basal autophagy through activation of the MEK/ERK pathway
    José M. Bravo-San Pedro
    Mireia Niso-Santano
    Rubén Gómez-Sánchez
    Elisa Pizarro-Estrella
    Ana Aiastui-Pujana
    Ana Gorostidi
    Vicente Climent
    Rakel López de Maturana
    Rosario Sanchez-Pernaute
    Adolfo López de Munain
    José M. Fuentes
    Rosa A. González-Polo
    Cellular and Molecular Life Sciences, 2013, 70 : 121 - 136
  • [3] G2019S LRRK2 mutant fibroblasts from Parkinson's disease patients show increased sensitivity to neurotoxin 1-methyl-4-phenylpyridinium dependent of autophagy
    Yakhine-Diop, Sokhna M. S.
    Bravo-San Pedro, Jose M.
    Gomez-Sanchez, Ruben
    Pizarro-Estrella, Elisa
    Rodriguez-Arribas, Mario
    Climent, Vicente
    Aiastui, Ana
    Lopez de Munain, Adolfo
    Fuentes, Jose M.
    Gonzalez-Polo, Rosa A.
    TOXICOLOGY, 2014, 324 : 1 - 9
  • [4] Axonal Lysosomal Assays for Characterizing the Effects of LRRK2 G2019S
    Bhatia, Priyanka
    Bickle, Marc
    Agrawal, Amay A.
    Truss, Buster
    Nikolaidi, Aikaterina
    Brockmann, Kathrin
    Reinhardt, Lydia
    Vogel, Stefanie
    Szegoe, Eva M.
    Pal, Arun
    Hermann, Andreas
    Mikicic, Ivan
    Yun, Maximina
    Falkenburger, Bjoern
    Sterneckert, Jared
    BIOLOGY-BASEL, 2024, 13 (01):
  • [5] Glucocerebrosidase mutations are not found in association with LRRK2 G2019S in subjects with parkinsonism
    Eblan, Michael J.
    Scholz, Sonja
    Stubblefield, Barbara
    Gutti, Usha
    Goker-Alpan, Ozlern
    Hruska, Kathleen S.
    Singleton, Andrew B.
    Sidransky, Ellen
    NEUROSCIENCE LETTERS, 2006, 404 (1-2) : 163 - 165
  • [6] ULK1 and JNK are involved in mitophagy incurred by LRRK2 G2019S expression
    Zhu, Yuangang
    Wang, Chunyan
    Yu, Mei
    Cui, Jie
    Liu, Liang
    Xu, Zhiheng
    PROTEIN & CELL, 2013, 4 (09) : 711 - 721
  • [7] LRRK2 G2019S kinase activity triggers neurotoxic NSF aggregation
    Pischedda, Francesca
    Cirnaru, Maria Daniela
    Ponzoni, Luisa
    Sandre, Michele
    Biosa, Alice
    Perez Carrion, Maria
    Marin, Oriano
    Morari, Michele
    Pan, Lifeng
    Greggio, Elisa
    Bandopadhyay, Rina
    Sala, Mariaelvina
    Piccoli, Giovanni
    BRAIN, 2021, 144 : 1509 - 1525
  • [8] Exercise knowledge, barriers and motivators among LRRK2 G2019S mutation carriers
    Schootemeijer, S.
    Coker, D.
    Shelton, J. F.
    Chanoff, E.
    Rowbotham, H. M.
    Darweesh, S. K. L.
    Bloem, B. R.
    Cannon, P.
    de Vries, N. M.
    PARKINSONISM & RELATED DISORDERS, 2023, 113
  • [9] Synaptic function is modulated by LRRK2 and glutamate release is increased in cortical neurons of G2019S LRRK2 knock-in mice
    Beccano-Kelly, Dayne A.
    Kuhlmann, Naila
    Tatarnikov, Igor
    Volta, Mattia
    Munsie, Lise N.
    Chou, Patrick
    Cao, Li-Ping
    Han, Heather
    Tapia, Lucia
    Farrer, Matthew J.
    Milnerwood, Austen J.
    FRONTIERS IN CELLULAR NEUROSCIENCE, 2014, 8 : 1 - 11
  • [10] LRRK2 G2019S Mutations are Associated with an Increased Cancer Risk in Parkinson Disease
    Saunders-Pullman, Rachel
    Barrett, Matthew J.
    Stanley, Kaili M.
    San Luciano, Marta
    Shanker, Vicki
    Severt, Lawrence
    Hunt, Ann
    Raymond, Deborah
    Ozelius, Laurie J.
    Bressman, Susan B.
    MOVEMENT DISORDERS, 2010, 25 (15) : 2536 - 2541
123